|
ZNF259 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.676330E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.497400E-03 |
| Normal-vs-Stage2 |
1.040420E-01 |
| Normal-vs-Stage3 |
1.143370E-03 |
| Normal-vs-Stage4 |
1.459770E-03 |
| Stage1-vs-Stage2 |
7.691600E-01 |
| Stage1-vs-Stage3 |
1.986380E-01 |
| Stage1-vs-Stage4 |
1.589820E-01 |
| Stage2-vs-Stage3 |
2.586000E-01 |
| Stage2-vs-Stage4 |
1.746820E-01 |
| Stage3-vs-Stage4 |
6.986000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.555900E-03 |
| Normal-vs-AfricanAmerican |
1.381220E-01 |
| Normal-vs-Asian |
2.096400E-02 |
| Caucasian-vs-AfricanAmerican |
7.024800E-01 |
| Caucasian-vs-Asian |
9.128200E-01 |
| AfricanAmerican-vs-Asian |
6.681800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55469999999891E-05 |
| Normal-vs-Female |
1.285630E-02 |
| Male-vs-Female |
6.899300E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.795700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.843850E-03 |
| Normal-vs-Age(61-80Yrs) |
3.644000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.086560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.175160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.169200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.507600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.816000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.992800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.023200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.682600E-01 |
| Classical-VS-Follicular |
1.628810E-01 |
| Classical-VS-Other |
1.980380E-01 |
| Classical-VS-Normal |
1.990120E-02 |
| Tall-VS-Follicular |
8.154400E-01 |
| Tall-VS-Other |
5.953800E-01 |
| Tall-VS-Normal |
1.041730E-02 |
| Follicular-VS-Other |
6.173800E-01 |
| Follicular-VS-Normal |
3.035500E-03 |
| Other-VS-Normal |
1.718560E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.364800E-03 |
| Normal-vs-N1 |
2.995200E-04 |
| N0-vs-N1 |
7.195800E-02 |
|
|
